CNBC May 8, 2024
Sophie Kiderlin

Key Points

– Pharmaceutical giant AstraZeneca on Wednesday said it planned to withdraw its Covid-19 vaccine as demand for it has declined.

– Demand for the vaccine has tailed off as newer shots targeted toward specific variants of Covid-19 have become available, AstraZeneca said in a statement.

– The so-called Vaxzevria vaccine was developed with the University of Oxford and was one of the first shots against Covid-19 to hit the market during the pandemic.

Pharmaceutical giant AstraZeneca on Wednesday said it planned to withdraw its Covid-19 vaccine as demand for it has declined.

Demand for AstraZeneca’s Vaxzevria vaccine began tapering off as new vaccines tailored to specific Covid variants have emerged, the pharmaceutical company said in a statement.

“As...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Pharma / Biotech, Public Health / COVID
CNS-Focused Rapport Therapeutics Preps IPO to Back Phase 2-Ready Epilepsy Drug
Balancing Weight-loss Medication Cost and Care
Marijuana rescheduling moves businesses into ‘uncharted territory’
Orforglipron: the new kid on the GLP-1 block
GLP-1 Agonist Safety Risks and Obesity Stigma with Kevin Peterson, MD, MPH

Share This Article